Search Results (511)

Coagulation–flocculation, historically reliant on simple inorganic salts, has evolved into a technically sophisticated process that is central to the removal of turbidity, suspended solids, organic matter, and an expanding array of micropollutants from complex wastewaters. This review synthesizes six decades of research, charting the transition from classical aluminum and iron salts to high-performance polymeric, biosourced, and hybrid coagulants, and examines their comparative efficiency across multiple performance indicators—turbidity removal (>95%), COD/BOD reduction (up to 90%), and heavy metal abatement (>90%). Emphasis is placed on recent innovations, including magnetic composites, bio–mineral hybrids, and functionalized nanostructures, which integrate multiple mechanisms—charge neutralization, sweep flocculation, polymer bridging, and targeted adsorption—within a single formulation. Beyond performance, the review highlights persistent scientific gaps: incomplete understanding of molecular-scale interactions between coagulants and emerging contaminants such as microplastics, per- and polyfluoroalkyl substances (PFAS), and engineered nanoparticles; limited real-time analysis of flocculation kinetics and floc structural evolution; and the absence of predictive, mechanistically grounded models linking influent chemistry, coagulant properties, and operational parameters. Addressing these knowledge gaps is essential for transitioning from empirical dosing strategies to fully optimized, data-driven control. The integration of advanced coagulation into modular treatment trains, coupled with IoT-enabled sensors, zeta potential monitoring, and AI-based control algorithms, offers the potential to create “Coagulation 4.0” systems—adaptive, efficient, and embedded within circular economy frameworks. In this paradigm, treatment objectives extend beyond regulatory compliance to include resource recovery from coagulation sludge (nutrients, rare metals, construction materials) and substantial reductions in chemical and energy footprints. By uniting advances in material science, process engineering, and real-time control, coagulation–flocculation can retain its central role in water treatment while redefining its contribution to sustainability. In the systems envisioned here, every floc becomes both a vehicle for contaminant removal and a functional carrier in the broader water–energy–resource nexus. Full article

UV radiation is responsible for acute and chronic adverse effects on the skin. In recent years, it has been shown that various phenolic acids, particularly cinnamic acid derivatives, prevent some of these effects. In the present study, the design and synthesis of three esters of ferulic acid, analogues of the octyl methoxycinnamate (OMC), one of the most commercially used filters, are presented. The esters were evaluated for their photoprotective activity against UVA and UVB radiation. The ester 3b exhibited an SPF of 9.22 and a λ_c value of 343.9, higher than the values of OMC (SPF value: 8.19, λ_c value: 337.7). The development and optimization of a novel encapsulation process of the synthesized esters in nanostructured lipid carriers (NLCs) and coating of the NLCs with chitosan was also performed. The optimization of the coating processes was performed using a Box–Behnken experimental design. The optimal nanosystems exhibited a size of 117.0 ± 5 nm, enhanced stability in dispersion, and 78% encapsulation efficiency. The nanoparticles were characterized by ATR/FT–IR, TGA, and TEM. Incorporation of the nanoparticle dispersions in a sunscreen formulation increased the SPF factor of the formulation up to 48%. The esters and nanosystems also showed a satisfactory ability to inhibit the peroxidation of linoleic acid (AAPH induced lipid peroxidation assay) (74–91% inhibition). Full article

To enhance the scope of therapeutic interventions using star polymeric nanoparticles of desired concentrations, an understanding of the effect of converting aqueous formulations into stable redispersible dry powders by freeze drying on their physicochemical and biological properties is essential. We demonstrate that parameters such as the choice of the cryoprotectant, its molecular weight, and concentration play an important role during lyophilization and reconstitution processes. We hypothesized that utilizing cryoprotectants akin to shell-forming polymers may be ideal in protection against aggregation and keeping the nanostructures intact during lyophilization and reconstitution, as well as retaining the overall biological efficacy of their cargo. Through an evaluation of miktoarm polymer-based nanoparticles, we demonstrate that PEG_2k at 1% w/v concentration provides the optimized cryoprotection, and the resulting solid formulations upon redispersion in an aqueous medium preserve the desired nanoparticle and curcumin properties. PEG_2k at 1% w/v is more efficient than PEG_5k and saccharides including glucose, sucrose, trehalose, and mannitol in enhancing the integrity of micelles during lyophilization and reconstitution. Addition of PEG_2k 1% w/v (with or without lyophilization and redispersion) enhances drug release in PBS buffer, while it has no impact in the cell culture media. Nanoformulations protect endothelial cells from cytotoxicity of curcumin, and addition of cryoprotectant or the lyophilization/redispersion processes did not impair anti-inflammatory efficacy of curcumin. Full article

Ginsenosides, the primary bioactive components of Panax ginseng, have demonstrated significant immunomodulatory potential. While major ginsenosides have been extensively studied, rare ginsenosides produced through deglycosylation, heating, and steaming show enhanced biological activities with improved bioavailability. This review aimed to comprehensively analyze the immunomodulatory mechanisms, structure-activity relationships (SARs), therapeutic applications, and clinical translation strategies of five emerging rare ginsenosides: F1, Rg5, Rk1, Rh1, and Rg2. We conducted a comprehensive literature review examining the production methods, immunological effects, molecular mechanisms, pharmacokinetics, safety profiles, and clinical applications of these five compounds. Analysis focused on chemical structures, immune cell modulation, signaling pathways, disease model efficacy, and bioavailability enhancement strategies. Ginsenoside F1 uniquely demonstrated immunostimulatory effects, enhancing natural killer (NK) cell cytotoxicity and macrophage phagocytosis through mitogen-activated protein kinase (MAPK)/nuclear factor-κB (NF-κB) activation. Conversely, Rg5, Rk1, Rh1, and Rg2 exhibited anti-inflammatory properties via distinct mechanisms: Rg5 through Toll-like receptor 4 (TLR4)/NF-κB inhibition, Rk1 via triple pathway modulation (NF-κB, p38 MAPK, signal transducer and activator of transcription (STAT)), Rh1 by selective p38 MAPK and STAT1 inhibition, and Rg2 through modulation of both central nervous system (neuroinflammation) and peripheral organ systems. Structure-activity analysis revealed that sugar moiety positions critically determine immunological outcomes. Crucially, advanced delivery systems including nanostructured lipid carriers, self-microemulsifying systems, and specialized liposomes have overcome the major translational barrier of poor bioavailability, achieving up to 2.6-fold improvements and enabling clinical development. Safety assessments demonstrated favorable tolerability profiles across preclinical and clinical studies. These five rare ginsenosides represent promising immunomodulatory agents with distinct therapeutic applications. F1’s unique immunostimulatory properties position it for cancer immunotherapy, while the complementary anti-inflammatory mechanisms of Rg5, Rk1, Rh1, and Rg2 offer opportunities for precision medicine in inflammatory diseases. Advanced formulation technologies and optimized production methods now enable their significant clinical translation potential, providing promising therapeutic options for immune-related disorders pending further development. Full article

Background: Sustained-release (SR) formulations of non-steroidal anti-inflammatory drugs (NSAIDs) aim to prolong therapeutic activity, reduce dosing frequency, and improve patient adherence. However, currently marketed SR NSAIDs exhibit persistent limitations, including incomplete control over release kinetics, high interpatient variability in bioavailability, limited reduction in gastrointestinal adverse effects, and insufficient dose flexibility for individualized therapy. In many cases, conventional excipients and release mechanisms remain predominant, leaving drug-specific physicochemical and pharmacokinetic constraints only partially addressed. These gaps highlight the need for a comprehensive synthesis of recent technological advances to guide the development of more effective, patient-centered delivery systems. Methods: A narrative literature review was conducted using Web of Science and PubMed databases to identify original research articles and comprehensive technological studies on oral SR formulations of NSAIDs and paracetamol published between January 2020 and March 2025. Inclusion criteria focused on preclinical and technological research addressing formulation design, excipient innovations, and manufacturing approaches. Results: Sixty-four studies met the inclusion criteria, encompassing polymeric matrices (31%), lipid-based carriers (18%), microspheres/hydrogel beads/interpenetrating polymer networks (30%), nanostructured systems (11%), and hybrid platforms (10%). The most common strategies involved pH-dependent release, mucoadhesive systems, and floating drug delivery, aiming to optimize release kinetics, minimize mucosal irritation, and sustain therapeutic plasma levels. Advances in manufacturing—such as hot-melt extrusion, 3D printing, electrospinning, and spray drying—enabled enhanced control of drug release profiles, improved stability, and in some cases up to 30–50% prolongation of release time or reduction in Cmax fluctuations compared with conventional formulations. Conclusions: Recent formulation strategies show substantial potential to overcome long-standing limitations of SR NSAID delivery, with expected benefits for patient compliance and quality of life through reduced dosing frequency, better tolerability, and more predictable therapeutic effects. Nevertheless, integration of in vitro performance with pharmacokinetic and clinical safety outcomes remains limited, and the translation to clinical practice is still in its early stages. This review provides a comprehensive overview of current technological trends, identifies persisting gaps, and proposes future research directions to advance SR NSAID systems toward safer, more effective, and patient-focused therapy. Full article

This study presents an exact analytical investigation into the static response of helical single-walled carbon nanotube (SWCNT) beams based on Eringen’s differential nonlocal elasticity theory, which captures nanoscale effects arising from interatomic interactions. A key contribution of this work is the derivation of the governing equations for helical SWCNT beams, based on the nonlocal Euler–Bernoulli theory, followed by their exact analytical solution using the initial value method. To the best of the authors’ knowledge, this represents the first closed-form formulation for such complex nanostructures using this theoretical framework of nonlocal elasticity theory. The analysis considers both cantilevered and clamped–clamped boundary conditions, under various concentrated force and moment loadings applied at the ends and midpoint of the helical beam. Displacements and rotational components are expressed in the Frenet frame, enabling direction-specific evaluation of the deformation behaviour. Parametric studies are conducted to investigate the influence of geometric parameters—such as the winding angle ($\alpha$) and aspect ratio ($R/d$) and the nonlocal parameter ($R/\gamma$). Results show that nonlocal elasticity theory consistently predicts higher displacements and rotations than the classical local theory, revealing its importance for accurate modelling of nanoscale structures. The proposed analytical framework serves as a benchmark reference for the modelling and design of nanoscale helical structures such as nano-springs, actuators, and flexible nanodevices. Full article

Nanostructures with the two-dimensional (2D) periodicity are attracting increasing attention due to their promising applications in planar optical devices and their potential for scalable industrial production. While Rigorous Coupled-Wave Analysis (RCWA) has proven to be an efficient electromagnetic solver for simulating the diffraction of large-scale periodic nanostructures, it has been largely applied in nanostructures with one-dimensional (1D) periodicity and suffers from potentially low computational stability. In this study, we present a step-by-step formulation of the RCWA algorithm for 2D stratified grating structures. Through dimensionality reduction, we show that the boundary conditions in 2D gratings can be transformed into forms analogous to those of 1D gratings. Additionally, we implement a hybrid matrix algorithm to enhance the computational stability of the RCWA. The stability and accuracy of the hybrid matrix-enhanced RCWA algorithm are compared with other recursive methods. An exemplary application in metalens demonstrates the effectiveness of our algorithms. Full article

Background: The management of triple-negative breast cancer (TNBC) remains a therapeutic challenge due to the presence of multidrug resistance (MDR) and hypoxia-induced chemoresistance, both of which substantially reduce the efficacy of conventional chemotherapy. Although certain natural compounds have shown the ability to modulate these resistance mechanisms, their clinical application is hindered by poor solubility and limited bioavailability. Among such phenolic compounds, 7-hydroxytyrosol (HTyr)—a phenolic compound from olive oil and olive leaves—has been reported to modulate hypoxia-inducible factor-1 (HIF-1). Methods: In this study, we developed hyaluronic acid (HA)-decorated solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for the targeted and synergistic co-delivery of paclitaxel (PTX) and hydroxytyrosol carboxylic acid esters (C_n-HTyrCA), precursors that share the antioxidant biphenolic moiety with HTyr. Results: Among the formulations tested, SLNs of trilaurin (TL) exhibited the highest entrapment efficiency (EE%), optimal average particle size, Zeta potential, and good colloidal stability. Of the synthesized C_n-HTyrCA derivatives, C₈- and C₁₀-HTyrCA showed superior loading capacity. In vitro release profiles indicated a sustained drug release pattern for both nanoparticles. HA decoration led to a marked increase in particle size and induced a shift in surface charge, confirming successful decoration and suggesting enhanced targeting potential via HA-CD44 interaction. Cytotoxicity assays conducted on MDA-MB-231 cells showed that PTX-loaded TL-SLNs exerted enhanced antitumor activity, particularly when HA-decorated, and a synergistic effect was observed upon co-administration with SLNs loaded with C₈-HTyrCA. Conclusions: Overall, our findings support the potential of SLN as a promising strategy to overcome key resistance mechanisms in TNBC, enabling reduced chemotherapeutic dosing and improving therapeutic outcomes. Full article

The natural wound healing process is often insufficient to restore tissue integrity in the case of chronic wounds, particularly when skin disruption is accompanied by pathological complications. The severity of these wounds is frequently exacerbated by persistent inflammation and the formation of bacterial biofilms, which significantly hinder skin regeneration. In this study, a pharmaceutical hydrogel-based wound dressing was developed and evaluated, incorporating silver nanoparticles synthesized with cinnamon essential oil that serves as both a stabilizer and antimicrobial agent, polymeric beta-carotene nanoparticles, and Centella asiatica extract. The work details the synthesis of both types of nanoparticles, their integration into an alginate-based matrix, and the subsequent formulation of composite dressings. The influence of each therapeutic agent on the morphology and structural characteristics of the dressings was demonstrated, along with the evaluation of their antimicrobial performance against both Gram-positive and Gram-negative bacterial strains. The antimicrobial effects observed within the first 24 h, critical for wound dressing application, highlight the potential of the developed materials for effective chronic wound management. A comprehensive set of analyses was performed to characterize the synthesized nanostructures and the final dressings. These included XRD, FTIR, SEM, EDS, and DLS. Additionally, swelling and degradation tests were conducted to assess hydrogel performance, while antimicrobial and antibiofilm activities were tested against Staphylococcus aureus and Escherichia coli over a 24-h period. The biocompatibility screening of the alginate-based wound dressings was performed on human keratinocyte cells and revealed that the incorporation of beta-carotene and Centella asiatica into alginate-based wound dressings effectively mitigates silver-induced cytotoxicity and oxidative stress and determines the development of highly biocompatible wound dressings. This paper presents an alginate hydrogel co-loaded with Ag nanoparticles, BC@PVP, and Centella asiatica extract that balances antimicrobial efficacy with cytocompatibility. Pairing silver with natural antioxidant/anti-inflammatory components mitigates cell stress while retaining broad activity, and the nanoparticle choice tunes pore architecture to optimize moisture and exudate control in chronic wounds. Full article

The integration of nanomaterials within hydrogel scaffolds offers significant promise in bone tissue engineering by improving mechanical performance and modulating cellular responses through mechanotransductive and biochemical signaling. Previous studies have demonstrated that nanodiamonds (NDs) incorporated in electrospun microfibrillar meshes enhance cellular adhesion, spreading, and cytoskeletal organization through localized mechanical reinforcement. However, the effects of ND loading into soft, bioinert three-dimensional hydrogel matrices remain underexplored. Here, we developed nanostructured 3D printing inks composed of gellan gum (GG) supplemented with a low content of ND nanoadditive (0–3% w/v). ND integration improved the shear-thinning properties of the formulation, enabling consistent filament formation and reliable extrusion-based 3D printing. Structural and mechanical assessments confirmed enhanced scaffold morphology, reduced deformation, and improved morphostructural integrity under compression and increased local stiffness at 2% ND loading (GG_ND2%). Biological assessments revealed that increasing ND content enhanced murine preosteoblast viability, proliferation, and attachment, particularly in GG_ND2%. Furthermore, bioactivation of the GG_ND2% formulation with icariin (ICA), a bioflavonoid known for its osteogenic and angiogenic activity, amplified the beneficial cellular responses of MG-63 cells to ND loading, promoting enhanced surface mineralization and improved cell–matrix interactions. Collectively, these findings highlight the potential of ND-reinforced GG scaffolds bioactivated with ICA, integrating structural reinforcement and biological functionalities that may support osteogenic responses. Full article

Home-compostable, biobased films were developed by blending poly(lactic acid) (PLA) with poly(butylene succinate-co-adipate) (PBSA). Among the formulations, the PLA/PBSA 60/40 blend demonstrated strong potential for industrial film production due to its enhanced flexibility and tear resistance. Thanks to their thermoplastic nature, these films can be applied to various substrates—such as paper or paperboard—and are easily recyclable within industrial processing environments. In this study, nanostructured clay and talc were incorporated into PLA/PBSA 60/40-based films to produce composites, which were evaluated for their effectiveness in limiting the diffusion of moisture from high-humidity soft cheeses. The materials’ melt fluidity and tensile properties were also characterized, and the composite morphology was examined using electron microscopy. The results revealed that the filler type significantly affected both the morphological structure and barrier performance, highlighting the critical role of material composition in the development of effective and environmentally sustainable packaging solutions. The biobased PLA/PBSA (60/40) films, particularly those filled with talc, exhibited high processability, flexibility, and effectiveness as a moisture barrier for dairy packaging. Although not yet feasible as a direct LDPE substitute without increasing their thickness, their low mass loss points to their strong potential for sustainable applications—especially when paired with paperboard in rigid packaging. Full article

Lipid-based nanocarriers are ideal drug delivery systems for transdermal administration due to their biocompatibility and biodegradability. Their lipophilicity and/or similarity to the natural lipids of the epidermis enable intermolecular interactions with the lipid membrane and therefore result in effective passage through the skin. The purpose of this review is to focus on lipid-based drug delivery nanoplatforms administered via the transdermal route by summarizing the most recent developments with the intention of fast clinical translation. Liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), ethosomes, and transfersomes exhibit ideal physicochemical characteristics and encapsulation efficiency to enhance the effectiveness of the incorporated Active Pharmaceutical Ingredients (APIs). The state of the art for fabricating transcutaneous lipid drug delivery nanoparticles and the strategies for overcoming the current obstacles, as well as the added value of novel formulations, will be discussed within the scope of Quality by Design applications. The limitations and challenges that still exist will also be considered. Full article

Plant-derived compounds offer immense therapeutic potential, yet many suffer from limited solubility, instability, and poor bioavailability, restricting their clinical application. Curcumin, a polyphenol extracted from Curcuma longa, is one such molecule, with proven antioxidant and anti-inflammatory properties. To overcome its pharmacokinetic limitations, we developed Jamamina, a sustainable nanostructured lipid carrier (NLC) system incorporating curcumin and a Natural Deep Eutectic Solvent (NaDES) phase composed of malic acid and betaine. The bioinspired formulation, based on Amazonian tucumã butter and jambu oil, achieved high encapsulation efficiency (>80%) and curcumin amorphization, enhancing solubility and colloidal stability. In vitro assays with L132 demonstrated potent antioxidant activity (DPPH), a significant reduction in pro-inflammatory cytokines (TNF-α and IL-6), and upregulation of IL-10. The system also suppressed MMP-2/9 activity and preserved cytoskeletal integrity under oxidative stress. These findings highlight Jamamina as a multifunctional, eco-friendly nanoplatform that enables the pharmacological application of plant-derived curcumin, representing a promising platform for modulating redox balance and investigating inflammation in epithelial-like contexts. Full article

Azelaic acid (AzA), a saturated dicarboxylic acid, is indicated for the treatment of acne vulgaris, rosacea, melasma, and post-inflammatory hyperpigmentation. Its antimicrobial, anti-inflammatory, and antimelanogenic properties support its use; however, its poor aqueous solubility and limited skin permeability constrain its optimal topical delivery. This review summarizes clinical evidence and advances in formulations—including conventional vehicles, polymeric/lipid nanocarriers, and deep eutectic solvent (DES) systems—to promote more effective and well-tolerated use. Across indications, 15–20% azelaic acid (AzA) formulations produced clinically meaningful improvements with mild, transient local irritation. For acne vulgaris, reductions in inflammatory and noninflammatory lesions were comparable to those of topical retinoids/adapalene, and tolerability was superior in some studies. For rosacea, the 15% gel formulation was comparable to metronidazole in reducing papules, pustules, and erythema while maintaining negligible systemic exposure. In melasma and other dyschromias, 20% cream demonstrated efficacy similar to hydroquinone, exhibiting a favorable safety profile. Advanced delivery systems, including liposomes, niosomes/ethosomes, nanostructured lipid carriers, microemulsions, nanosponges, and DES platforms, increased AzA solubilization, cutaneous deposition, and stability. This enabled dose-sparing strategies and improved adherence. Data on AzA cocrystals and ionic salts suggest additional control over release and irritation. AzA remains a versatile and well-tolerated dermatologic agent whose performance is strongly vehicle-dependent. Rational selection and engineering of carriers, particularly DES-integrated polymeric and lipid systems, can mitigate solubility and permeability limitations, enhance skin targeting, and reduce irritation in the treatment of acne and rosacea. Full article

In this work, bemotrizinol (BMTZ), a broad-spectrum UV-filter, was loaded into nanostructured lipid carriers (NLC) whose lipid matrix contained different oils (isopropyl myristate, decyl oleate, caprylic/capric triglyceride) to assess the effects of the lipid core composition on the properties of the resulting NLC. Subsequently, the effects of incorporating different concentrations of optimized BMTZ-loaded NLC on the technological properties of O/W emulsions (pH, viscosity, spreadability, occlusion factor, in vitro BMTZ release, skin permeation, and in vitro sun protection factor) were assessed. The optimized BMTZ-loaded NLC contained 3.0% w/w of isopropyl myristate and showed mean size = 190.6 ± 9.8 nm, polydispersity index = 0.153 ± 0.013, ζ-potential = −10.6 ± 1.7 mV, and loading capacity = 8% w/w. The incorporation of increasing concentrations (5, 10, 20% w/w) of optimized BMTZ loaded into emulsions provided a slight increase in spreadability, lower viscosity, and no change in pH, occlusion factor, and BMTZ release compared to emulsions containing free BMTZ. No BMTZ skin permeation was observed from all formulations. About a 20% increase in sun protection factor values was obtained for vehicles containing BMTZ-loaded NLC compared with formulations incorporating the same amount of free BMTZ. Therefore, incorporating BMTZ-loaded NLC into emulsions could be a promising strategy to develop safer and more effective sunscreen formulations. Full article